Also known as: CJC-1295 DAC, Modified GRF 1-29
CJC-1295 is a synthetic peptide that functions as a growth hormone releasing hormone (GHRH) analog. It belongs to the category of growth hormone peptides and is designed to stimulate the secretion of growth hormone from the pituitary gland. CJC-1295 is notable for its extended half-life, which allows for prolonged action in the body compared to other GHRH analogs.
This peptide is often studied for its potential effects on growth hormone levels, metabolism, and overall physiological function. Its unique structure enables it to bind to the growth hormone receptor, promoting increased release of growth hormone in a controlled manner.
CJC-1295 operates by mimicking the natural growth hormone releasing hormone, which is crucial for stimulating the release of growth hormone from the anterior pituitary gland.
Upon administration, CJC-1295 binds to specific receptors in the pituitary gland, triggering a cascade of biological events that lead to the secretion of growth hormone. This process not only enhances growth hormone levels but also influences various metabolic pathways, contributing to muscle growth and fat metabolism.
CJC-1295 serves as a significant tool in research related to growth hormone dynamics and its physiological effects. Its ability to stimulate growth hormone release positions it as a valuable peptide in the study of muscle growth, fat loss, and overall metabolic health.
Last updated: Jan 8, 2026